REG - Royal Bank of Canada - Publication of a Prospectus

Royal Bank of CanadaAnnouncement

09/03/2022 14:45

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220309:nRSI2210Ea&default-theme=true

RNS Number : 2210E  Royal Bank of Canada  09 March 2022

Regulatory Announcement

 

 

Royal Bank of Canada

March 9, 2022

 

Publication of Prospectus

 

Not for release, publication or distribution, directly or indirectly, in or
into the United States.

 

Notice to Noteholders and Publication of Amended and Restated Final Terms

 

Royal Bank of Canada has today given notice to Noteholders relating to the
issue of the EUR450,000,000 1.034 per cent. Senior Notes due January 25, 2034,
Series 64148 (ISIN XS2437825388) issued on January 31, 2022 (the "Notes")
pursuant to its Programme for the Issuance of Securities (the "Programme").

 

Noteholders have been informed that pursuant to Condition 14 (fourth
paragraph, item (ii) of the first sentence), the Final Terms dated January 27,
2022 relating the Notes have been amended and restated on March 9, 2022 to
cure a manifest error in the Notes (the "Amended and Restated Final Terms").
Item 5(iii) (Minimum Trading Size) has been amended to read "EUR100,000"
instead of "EUR1,000".

All other Conditions remain unchanged.

 

The Issuer has today published the Amended and Restated Final Terms and
submitted them to the London Stock Exchange. They are available to view at
http://www.rns-pdf.londonstockexchange.com/rns/2210E_1-2022-3-9.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/2210E_1-2022-3-9.pdf)

 

 

DISCLAIMER - INTENDED ADDRESSEES

 

Please note that the information contained in the Prospectus dated July 23,
2021, as supplemented by the 1(st) Supplementary Notes Base Prospectus dated
August 31, 2021 and the 2(nd) Supplementary Notes Base Prospectus dated
January 5, 2022 relating to the Programme (the "Prospectus") and the Amended
and Restated Final Terms, may be addressed to and/or targeted at persons who
are residents of particular countries (specified in the Prospectus) only and
is not intended for use and should not be relied upon by any person outside
these countries and/or to whom the offer contained in the Amended and Restated
Final Terms is not addressed.  Prior to relying on the information contained
in the Amended and Restated Final Terms you must ascertain from the
Prospectus, as supplemented by these Amended and Restated Final Terms, whether
or not you are part of the intended addressees of the information contained
therein.

 

The Notes have not been and will not be registered under the United States
Securities Act of 1933, as amended (the "Securities Act") or the securities
laws of any state of the United States and are subject to United States tax
law requirements.  Subject to certain exceptions, the Notes may not be
offered, sold or delivered, directly or indirectly, in or into the United
States or to or for the account or benefit of a "US person" (as defined in
Regulation S under the Securities Act).  No public offering of the Notes is
being made in the United States.  This announcement does not constitute an
offer to sell or a solicitation to buy securities in the United States or in
any other jurisdiction where such offer or solicitation would be unlawful.

 

Your right to access this service is conditional upon complying with the above
requirement.

 

UK MIFIR professionals / ECPs-only / No PRIIPs KID - Manufacturer target
market (UK MIFIR product governance) is eligible counterparties and
professional clients only (all distribution channels). No PRIIPs key
information document (KID) has been prepared as not available to retail in EEA
and the UK.

 

To view the full document, please paste the following URLs into the address
bar of your browser.

 

http://www.rns-pdf.londonstockexchange.com/rns/2210E_1-2022-3-9.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/2210E_1-2022-3-9.pdf)

 

 

 

For further information, please contact

Erin Dion

Assistant General Counsel

Royal Bank of Canada

Telephone Number:  (416) 974-4103

Fax Number:  (416) 955-2032

Email:  erin.dion@rbc.com

 

 

 

 

END

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  PDIFZGGFFLLGZZM